Prospective Safety and Feasibility trial of Nivolumab and Stereotactic Ablative Radiation Therapy (SAbR) for Metastatic Clear Cell Renal Cell Carcinoma (mRCC)

被引：0
|
作者：
All, S. [1 ]
de Leon, A. Diaz [2 ]
Mohamad, O. [3 ]
Choy, H. [4 ]
Hammers, H. [5 ]
Sanjeevaiah, A. [6 ]
Arafat, W. [6 ]
Courtney, K. [5 ]
Timmerman, R. D. [4 ]
Brugarolas, J. [7 ]
Hannan, R. [4 ]
机构：
[1] UT Southwestern, Dept Radiat Oncol, Dallas, TX USA
[2] UT Southwestern, Dept Radiol, Dallas, TX USA
[3] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA USA
[4] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA
[5] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[6] UT Southwestern, Dept Hematol Oncol, Dallas, TX USA
[7] Univ Texas Southwestern Med Ctr Dallas, Dept Hematol Oncol, Dallas, TX 75390 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2020年 / 108卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4086
引用
收藏
页码：E896 / E897
页数：2
相关论文
共 50 条
  • [31] STEREOTACTIC ABLATIVE RADIATION THERAPY (SABR) FOR TREATMENT OF RENAL CELL CARCINOMA (RCC) WITH INFERIOR VENA CAVA TUMOR THROMBUS (IVC-TT)
    Freifeld, Yuval
    Pedrosa, Ivan
    Mcloughlin, Mark
    Correa, Rohann
    Louie, Alexander V.
    Maldonado, Jose Alberto
    Tang, Chad
    Kadow, Brian
    Kutikov, Alexander
    Uzzo, Robert
    Porta, Camillo
    Bucknell, Nicholas W.
    Siva, Shankar
    Brugarolas, James
    Margulis, Vitaly
    Hannan, Raquibul
    JOURNAL OF UROLOGY, 2020, 203 : E200 - E200
  • [32] A phase Ib study of safety and preliminary efficacy of extracranial stereotactic body radiation therapy (SBRT) in patients with metastatic renal cell carcinoma (mRCC) treated with systemic therapy
    Dengina, N.
    Mitin, T.
    Gamayunov, S.
    Safina, S.
    Kreinina, Y.
    Tsimafeyeu, I.
    ANNALS OF ONCOLOGY, 2018, 29
  • [33] irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical Trial
    Pignon, Jean-Christophe
    Jegede, Opeyemi
    Shukla, Sachet A.
    Braun, David A.
    Horak, Christine E.
    Wind-Rotolo, Megan
    Ishii, Yuko
    Catalano, Paul J.
    Grosha, Jonian
    Flaifel, Abdallah
    Novak, Jesse S.
    Mahoney, Kathleen M.
    Freeman, Gordon J.
    Sharpe, Arlene H.
    Hodi, F. Stephen
    Motzer, Robert J.
    Choueiri, Toni K.
    Wu, Catherine J.
    Atkins, Michael B.
    McDermott, David F.
    Signoretti, Sabina
    CLINICAL CANCER RESEARCH, 2019, 25 (07) : 2174 - 2184
  • [34] Stereotactic body radiotherapy (SBRT)/stereotactic ablative body radiotherapy (SABR) for "radioresistant" renal cell carcinoma (RCC)
    Ishiyama, Hiromichi
    Blanco, Angel I.
    Lo, Simon S.
    Butler, E. Brian
    Teh, Bin S.
    JOURNAL OF RADIATION ONCOLOGY, 2014, 3 (04) : 339 - 346
  • [35] Outcomes of Multiple/All lesions Stereotactic Ablative Radiation Therapy (SABR) for Oligo-Metastatic Renal Cancer
    Ma, M. W.
    Liu, M. Z.
    Li, H. Z.
    Gao, X. S.
    Yin, H.
    Yang, K. W.
    Wang, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E208 - E208
  • [36] Durable response to nivolumab rechallenge in a patient with metastatic clear cell renal cell carcinoma
    Fujiwara, Motohiro
    Shimada, Wataru
    Yokoyama, Minato
    Koyanagi, Anri
    Shintaku, Hiroshi
    Fukuda, Shohei
    Waseda, Yuma
    Tanaka, Hajime
    Yoshida, Soichiro
    Fujii, Yasuhisa
    IJU CASE REPORTS, 2024, 7 (04) : 293 - 296
  • [37] NRG-GU012: Randomized phase II stereotactic ablative radiation therapy (SABR) for patients with metastatic unresected renal cell carcinoma (RCC) receiving immunotherapy (SAMURAI).
    Hall, William A.
    Karrison, Theodore
    McGregor, Bradley Alexander
    Barata, Pedro C.
    Nagar, Himanshu
    Tang, Chad
    Siva, Shankar
    Morgan, Todd Matthew
    Lang, Joshua Michael
    Kamran, Sophia C.
    Glide-Hurst, Carri
    Sundaram, Karthik
    Katz, Sharyn I.
    Feng, Felix Y.
    Mckay, Rana R.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [38] Lymphocytic myocarditis in a patient with metastatic clear cell renal cell carcinoma treated with Nivolumab
    Sauer, R.
    Kiewe, P.
    Desole, M.
    Schuler, M.
    Theissig, F.
    Roth, A.
    Mairinger, T.
    PATHOLOGE, 2017, 38 (06): : 535 - 539
  • [39] The Landscape of Stereotactic Ablative Radiotherapy (SABR) for Renal Cell Cancer (RCC)
    Moreno-Olmedo, Elena
    Sabharwal, Ami
    Das, Prantik
    Dallas, Nicola
    Ford, Daniel
    Perna, Carla
    Camilleri, Philip
    CANCERS, 2024, 16 (15)
  • [40] Effect of nivolumab on tumor growth rate (TGR) in metastatic renal cell carcinoma (mRCC).
    Mazza, Camille
    Arfi-Rouche, Julia
    Koscielny, Serge
    Caramella, Caroline
    Lahmar, Jihene
    Escudier, Bernard J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
12345